Grothey A - Search Results

1

Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.

Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, Pitot HC, Grothey A, Alberts SR, Sargent DJ. Franko J, et al. Among authors: grothey a. J Clin Oncol. 2012 Jan 20;30(3):263-7. doi: 10.1200/JCO.2011.37.1039. Epub 2011 Dec 12. J Clin Oncol. 2012. PMID: 22162570 Free PMC article. Clinical Trial.

2

Chemotherapy in elderly patients with colorectal cancer.

Köhne CH, Grothey A, Bokemeyer C, Bontke N, Aapro M. Köhne CH, et al. Among authors: grothey a. Ann Oncol. 2001 Apr;12(4):435-42. doi: 10.1023/a:1011170808734. Ann Oncol. 2001. PMID: 11398873 Free article. Review.

3

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment.

Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Grothey A, et al. J Clin Oncol. 2004 Apr 1;22(7):1209-14. doi: 10.1200/JCO.2004.11.037. J Clin Oncol. 2004. PMID: 15051767

4

A review of oxaliplatin and its clinical use in colorectal cancer.

Grothey A, Goldberg RM. Grothey A, et al. Expert Opin Pharmacother. 2004 Oct;5(10):2159-70. doi: 10.1517/14656566.5.10.2159. Expert Opin Pharmacother. 2004. PMID: 15461551 Review.

5

Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates.

Folprecht G, Grothey A, Alberts S, Raab HR, Köhne CH. Folprecht G, et al. Among authors: grothey a. Ann Oncol. 2005 Aug;16(8):1311-9. doi: 10.1093/annonc/mdi246. Epub 2005 May 3. Ann Oncol. 2005. PMID: 15870084 Free article.

6

FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.

Grothey A, Sargent DJ. Grothey A, et al. J Clin Oncol. 2005 May 20;23(15):3311-3. doi: 10.1200/JCO.2005.11.691. J Clin Oncol. 2005. PMID: 15908645 No abstract available.

7

Clinical trial designs for prospective validation of biomarkers.

Mandrekar SJ, Grothey A, Goetz MP, Sargent DJ. Mandrekar SJ, et al. Among authors: grothey a. Am J Pharmacogenomics. 2005;5(5):317-25. doi: 10.2165/00129785-200505050-00004. Am J Pharmacogenomics. 2005. PMID: 16196501

8

N0147: a randomized phase III trial of oxaliplatin plus 5-fluorouracil/leucovorin with or without cetuximab after curative resection of stage III colon cancer.

Alberts SR, Sinicrope FA, Grothey A. Alberts SR, et al. Among authors: grothey a. Clin Colorectal Cancer. 2005 Sep;5(3):211-3. doi: 10.3816/ccc.2005.n.033. Clin Colorectal Cancer. 2005. PMID: 16197625 Clinical Trial. No abstract available.

9

Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials.

Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, Labianca R, Seitz JF, O'Callaghan CJ, Francini G, Grothey A, O'Connell M, Catalano PJ, Blanke CD, Kerr D, Green E, Wolmark N, Andre T, Goldberg RM, De Gramont A. Sargent DJ, et al. Among authors: grothey a. J Clin Oncol. 2005 Dec 1;23(34):8664-70. doi: 10.1200/JCO.2005.01.6071. Epub 2005 Oct 31. J Clin Oncol. 2005. PMID: 16260700

10

Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line.

Grothey A, Sargent D. Grothey A, et al. J Clin Oncol. 2005 Dec 20;23(36):9441-2. doi: 10.1200/JCO.2005.04.4792. J Clin Oncol. 2005. PMID: 16361649 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

378 results

Search Page